Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia-Reference-Cited by-同舟云学术

Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia

Published:2021-11-29 Issue:11 Volume:4 Page:e2136246
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Menichetti Francesco¹,Popoli Patrizia²,Puopolo Maria³,Spila Alegiani Stefania²,Tiseo Giusy¹,Bartoloni Alessandro⁴,De Socio Giuseppe Vittorio⁵,Luchi Sauro⁶,Blanc Pierluigi⁷,Puoti Massimo⁸⁹,Toschi Elena¹⁰,Massari Marco²,Palmisano Lucia²,Marano Giuseppe¹¹,Chiamenti Margherita¹²,Martinelli Laura¹³,Franchi Silvia¹³,Pallotto Carlo¹⁴,Suardi Lorenzo Roberto¹¹⁴,Luciani Pasqua Barbara¹⁵,Merli Marco⁹,Fabiani Plinio¹⁶,Bertolucci Luca¹⁶,Borchi Beatrice⁴,Modica Sara⁴,Moneta Sara⁶,Marchetti Giulia¹⁷,d’Arminio Monforte Antonella¹⁷,Stoppini Laura¹⁸,Ferracchiato Nadia¹⁸,Piconi Stefania¹⁹,Fabbri Claudio²⁰,Beccastrini Enrico²¹,Saccardi Riccardo²¹,Giacometti Andrea²²,Esperti Sara⁷,Pierotti Piera⁷,Bernini Laura²³,Bianco Claudia²³,Benedetti Sara⁵,Lanzi Alessandra⁵,Bonfanti Paolo²⁴,Massari Marco²⁵,Sani Spartaco²⁶,Saracino Annalisa²⁷,Castagna Antonella²⁸,Trabace Luigia²⁹,Lanza Maria³⁰,Focosi Daniele³⁰,Mazzoni Alessandro³¹,Pistello Mauro³²,Falcone Marco¹,Palazzolo Roberto³³,Casari Salvatore³³,Occhionero Alessandro³³,Grazzini Tiziana³³,Silvestri Dina Leonarda³³,Iorio Mariacarla³³,Tosti Andrea³³,Francisci Daniela³³,Becattini Cecilia³³,Pirro Matteo³³,Marchesi Mauro³³,Bastianelli Sabrina³³,Pierucci Sara³³,Busti Chiara³³,Mencacci Antonella³³,Bozza Silvia³³,Camilloni Barbara³³,Annoni Valentina³³,Bellotto Chiara³³,Cioppi Adriano³³,Querci Giorgia³³,Ciusa Giacomo³³,Tassara Michela³³,Danise Anna³³,Chigiotti Silvia³³,Morelli Giovanna³³,Meini Micaela³³,Galfo Valentina³³,Ferranti Simone³³,Tagliaferri Enrico³³,Iapoce Riccardo³³,Barbieri Chiara³³,Forniti Arianna³³,Caroselli Claudio³³,Verdenelli Stefano³³,Monzani Fabio³³,Mazzetti Paola³³,Moscato Giovanna³³,Barchiesi Francesco³³,Andreotti Mauro³³,Baldanti Fausto³³,Binelli Andrea³³,Capobianchi Maria R³³,Da Cas Roberto³³,Di Sevo Daniela³³,Fazi Paola³³,Gasparrini Cinzia³³,Ippoliti Ilaria³³,Mancino Alessandra³³,Menniti Ippolito Francesca³³,Paoloni Francesca³³,Ruggeri Paola³³,Rughini Arianna³³,Salvi Emanuela³³,Sargentini Valeria³³,Trotta Maria P³³,Vignetti Marco³³,

Affiliation:

1. Infectious Disease Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy

2. National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy

3. Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy

4. Infectious and Tropical Diseases Unit, Florence Department of Medicine, Careggi University Hospital, Florence, Italy

5. Clinic of Infectious Diseases, “Santa Maria della Misericordia” Hospital, University of Perugia, Perugia, Italy

6. Infectious Disease Unit, Hospital of Lucca, Lucca, Italy

7. Infectious Diseases, Ospedale S. Maria Annunziata, Firenze, Italy

8. University of Milano-Bicocca School of Medicine, Milan, Italy

9. Azienda socio sanitaria territorial (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy

10. Research Coordination and Support Service (CoRi), Istituto Superiore di Sanità, Rome, Italy

11. Italian National Blood Centre, Rome, Italy

12. Unit of Infectious Diseases, Carlo Poma Hospital, Mantova, Italy

13. Internal Medicine, Unità Sanitaria Locale (USL)–Umbria 1, Ospedale Città di Castello, Città di Castello, Italy

14. Infectious Diseases Unit, San Giuseppe Hospital, Azienda USL Toscana Centro, Empoli, Italy

15. Centro Regionale Sangue, Servizio Immunotrasfusionale, Azienda Ospedaliera di Perugia, Perugia, Italy

16. Internal Medicine, Ospedale Unico della Versilia, Lido di Camaiore, Italy

17. Infectious Diseases Unit, Department of Health Sciences, ASST Santi Paolo e Carlo University Hospital, Milan, Italy

18. Internal Medicine, Ospedale di Foligno, Foligno, Italy

19. Infectious Diseases, Azienda Ospedaliera di Lecco, Lecco, Italy

20. Infectious Diseases, Ospedale San Jacopo, Pistoia, Italy

21. Cell Therapy and Transfusion Medicine, Careggi University Hospital, Florence, Italy

22. Azienda Ospedaliera Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy

23. Division of Infectious Diseases, Arezzo Hospital, Arezzo, Italy

24. Department of Infectious Diseases, ASST Monza, University of Milano-Bicocca, Milan, Italy

25. Infectious Disease Unit, Azienda USL–Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) di Reggio Emilia, Reggio Emilia, Italy

26. Infectious Diseases, Livorno Hospital, Livorno, Italy

27. Division of Infectious Diseases, Bari University Hospital, Bari, Italy

28. Infectious Diseases, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy

29. Department of Experimental and Clinical Medicine, University of Foggia, Foggia, Italy

30. North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy

31. Division of Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy

32. Division of Virology, University Hospital of Pisa, Retrovirus Center, Department of Translational Research, University of Pisa, Pisa, Italy

33. for the TSUNAMI Study group

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786680/menichetti_2021_oi_211022_1642100496.70738.pdf

Reference27 articles.

1. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial.;Li;JAMA,2020

2. Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).;Agarwal;BMJ,2020

3. A randomized trial of convalescent plasma in COVID-19 Severe Pneumonia.;Simonovich;N Engl J Med,2021

4. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.;Horby;Lancet,2021

5. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection.;Gharbharan;Nat Commun,2021

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the development of pharmacotherapeutics targeting SARS-CoV-2;Drug Discovery Today;2024-09

2. Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic;2024-08-12

3. Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-07

4. Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients;Life;2024-06-22

5. Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma;2024-05-18